How to Test for Metabolic Syndrome: Guide for Women

HealthRX.com

Metabolic syndrome is diagnosed from five measurements

Print or save as PDF

Key numbers

  • 24%Share of 14,719 initially healthy women who already had metabolic syndrome at study entrySource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 5.75 mg/LMedian C-reactive protein in women with all five metabolic syndrome criteria presentSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 31%Coefficient of variation of the HOMA-IR model's estimate of insulin resistanceSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026

At a glance

  • What the test is / Five measurements; three abnormal findings meet the harmonized criteria [1]
  • The five findings / Central obesity, raised triglycerides, low HDL cholesterol, raised blood pressure, raised fasting glucose [1]
  • What a visit needs / A blood sample, a blood pressure reading, a waist measurement [1]
  • Waist measurement / A preliminary screening tool in the harmonized definition, not an obligatory component [1]
  • Waist thresholds / Set by country or region; the IDF uses lower, ethnic-specific values [1]
  • Insulin or HOMA-IR / Not one of the five criteria [1]

What counts as a metabolic syndrome test?

Metabolic syndrome is a label applied to a cluster, not a result that comes back from one assay. The harmonized definition agreed by the major cardiology, diabetes and obesity organizations requires three abnormal findings out of five [1]. Those five are central obesity, dyslipidemia (raised triglycerides and lowered HDL cholesterol), raised blood pressure and raised fasting glucose [1].

The earlier AHA/NHLBI statement and the International Diabetes Federation definition differed mainly over central obesity: the IDF made it obligatory and used a lower, ethnic-specific waist threshold, while AHA/NHLBI did not [1]. The harmonizing statement settled on no obligatory component, kept waist measurement as a useful preliminary screening tool, and allowed national or regional waist cut points in the interim [1].

In practice, one appointment can cover it. A blood sample supplies triglycerides, HDL cholesterol and glucose. A blood pressure cuff supplies the fourth number. A tape measure supplies the fifth.

Questions worth asking

Choose the questions you want to keep

The five measurements, one by one

Waist circumference

This is the criterion where definitions diverge most, and the harmonized statement does not fix a single international number. The IDF requires central obesity as an entry condition and sets waist thresholds by ethnicity; the harmonized definition treats waist as a screening measurement and allows regional or national cut points [1]. Which waist number applies to a given woman therefore depends on which definition her clinician is using.

Triglycerides and HDL cholesterol

Both come off the same lipid panel, and together they make up the dyslipidemia component: raised triglycerides and lowered HDL cholesterol [1]. A woman can meet one and not the other, which is why the panel is read criterion by criterion rather than as a single cholesterol number.

Blood pressure

Raised blood pressure is one of the five findings and counts toward the total like any other [1].

Fasting glucose

The fifth finding is raised fasting glucose, so this criterion is defined on a fasting value [1].

Is there a blood test for insulin resistance?

Not one that forms part of the diagnosis. Insulin and the calculated HOMA-IR index are not among the five criteria [1]. HOMA-IR is derived from fasting insulin and fasting glucose using a model published in 1985; its estimate correlated well with the euglycaemic clamp (Rs = 0.88), but the model's own precision is limited, with a coefficient of variation of about 31% for insulin resistance [3].

Inflammation markers are a similar case: informative, not part of the criteria. In a cohort of 14,719 initially healthy women followed for eight years, 24% had metabolic syndrome at entry, and median C-reactive protein rose step by step with the number of criteria present — 0.68, 1.09, 1.93, 3.01, 3.88 and 5.75 mg/L for zero through five [4]. Among women who already had metabolic syndrome, the age-adjusted rate of future cardiovascular events was 3.4 per 1,000 person-years when CRP was below 3.0 mg/L and 5.9 per 1,000 person-years when it was above [4].

Does menopause change the test results?

The menopause transition is associated with changes in the underlying numbers. A 2003 review describes the shift from pre- to postmenopause as bringing more intra-abdominal fat, a more atherogenic lipid profile (higher LDL and triglycerides, lower HDL) and higher glucose and insulin levels [5]. Body composition data from the SWAN cohort, measured by DXA, show the rate of fat gain doubling at the start of the transition and lean mass declining, with both continuing until about two years after the final menstrual period; weight itself climbed steadily through premenopause without accelerating at the transition [6]. A separate review concluded that weight gain as such cannot be attributed to menopause, while the hormonal change is associated with more total and abdominal fat, and that estrogen therapy may partly prevent that shift [7].

Hormone therapy can also bear on the lipid numbers. The Premarin label lists increased triglycerides among its postmarketing adverse reactions and says to discontinue estrogen if severe hypertriglyceridemia occurs [8]. Progestogens are not interchangeable either: a review of progestogens in hormone therapy notes that those with higher androgenic potency can attenuate estrogen's favorable effect on the lipid profile, while progestogens devoid of androgenic properties do not exert these effects [9]. Premarin is not labeled for weight management [8].

Metabolic syndrome testing in PCOS

The five measurements are the same, but the prior probability is higher. A systematic review and meta-analysis including 27 studies in the meta-analysis found women with polycystic ovary syndrome had a higher prevalence of metabolic syndrome, odds ratio 3.35 (95% CI 2.44 to 4.59) [10]. The excess was significant in women with PCOS who were overweight or obese (OR 1.88, 95% CI 1.16 to 3.04) and not significant in lean women with PCOS (OR 1.45, 95% CI 0.35 to 6.12) [10]. Across studies, the variation in prevalence was explained by metabolic measures — waist circumference, HDL, triglycerides, blood pressure, BMI, two-hour glucose tolerance and HOMA-IR — but not by reproductive markers such as SHBG, testosterone or PCOS phenotype [10].

What people on Reddit report

Replies from a PCOS forum about how clinicians test for insulin resistance and which blood panels they order. These are not about the metabolic syndrome criteria directly.

Unlucky_Yak7162 · PCOS

It depends on where you live, but you can explain your symptoms to a doctor, and they may tell you to get an OGTT (Oral Glucose Tolerance Test).

A commenter says a doctor may order an oral glucose tolerance test after symptoms are explained, depending on location.

Read the source discussion

AH96_ · PCOS

These are the blood tests i did last time I went to my gynecologist who is a specialist in PCOS Lipid profile FBS Fasting insulin HOMA-IR

A commenter lists the blood panel their PCOS specialist ordered, including lipids, fasting glucose and insulin.

Read the source discussion

What the Diabetes Prevention Program tested

In the Diabetes Prevention Program, 3,234 adults with elevated fasting and post-load glucose (68% women) were assigned to placebo, metformin 850 mg twice daily, or a lifestyle program with goals of at least 7% weight loss and at least 150 minutes of physical activity per week. Over an average of 2.8 years, lifestyle change reduced diabetes incidence by 58% and metformin by 31%, both compared with placebo [2].

Check what you know

Think you have it? Try 5 quick questions and see what the article says.

1. According to the article, how many abnormal findings meet the harmonized criteria for metabolic syndrome?

Question 1 of 5

Score: 0 right, 0 of 5 answered

Frequently asked questions

What tests diagnose metabolic syndrome?
Five measurements: waist circumference, triglycerides, HDL cholesterol, blood pressure and fasting glucose. Three abnormal findings meet the harmonized criteria for metabolic syndrome [1].
Can I test for metabolic syndrome at home?
Two of the five measurements, waist circumference and blood pressure, can be taken at home with a tape measure and a cuff. Triglycerides, HDL cholesterol and fasting glucose come from blood tests, so the full set of five is not a home-only check [1].
How do the criteria sets differ?
Mainly over waist circumference. The International Diabetes Federation makes central obesity obligatory and sets waist thresholds by ethnicity, while the harmonized statement has no obligatory component, treats waist as a preliminary screening tool and allows national or regional cut points in the interim [1].
Does PCOS raise the odds of metabolic syndrome?
Yes. A meta-analysis found an odds ratio of 3.35 (95% CI 2.44 to 4.59) for metabolic syndrome in women with PCOS. The excess was significant in women with PCOS who were overweight or obese and not significant in lean women [10].
Does hormone therapy change the numbers?
It can bear on lipids. The Premarin label lists increased triglycerides as a postmarketing reaction and says to discontinue estrogen if severe hypertriglyceridemia occurs [8], and progestogens with higher androgenic potency can blunt estrogen's favorable lipid effect [9]. Separately, the menopause transition is associated with more abdominal fat and a more atherogenic lipid profile, including lower HDL, and estrogen therapy may partly prevent the shift in body composition [5][7].

References

Show all 11 referencesHide references
  1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5.
  2. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
  3. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9.
  4. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107(3):391-7.
  5. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88(6):2404-11.
  6. Greendale GA, Sternfeld B, Huang M, Han W, Karvonen-Gutierrez C, Ruppert K, et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019;4(5).
  7. Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, Shah D, et al. Understanding weight gain at menopause. Climacteric. 2012;15(5):419-29.
  8. U.S. National Library of Medicine, DailyMed. Premarin oral tablets (estrogens, conjugated) prescribing information. Premarin oral tablets (estrogens, conjugated) label
  9. Sitruk-Ware R. Progestogens in hormonal replacement therapy: new molecules, risks, and benefits. Menopause. 2002;9(1):6-15.
  10. Lim SS, Kakoly NS, Tan JWJ, Fitzgerald G, Bahri Khomami M, Joham AE, et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev. 2019;20(2):339-352.
  11. Reddit participants. How to get insulin resistance diagnosed? What were the results? (r/PCOS). Accessed 2026-11-11.
Evidence overview for How to Test for Metabolic Syndrome: Guide for Women